Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear receptor activity	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	8.74e-06	60	161	6	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	9.63e-06	61	161	6	GO:0098531
GeneOntologyMolecularFunction	G protein-coupled glutamate receptor activity	GRM1 GRM2 GRM3	4.17e-05	9	161	3	GO:0098988
GeneOntologyMolecularFunction	adenylate cyclase inhibiting G protein-coupled glutamate receptor activity	GRM1 GRM2 GRM3	4.17e-05	9	161	3	GO:0001640
GeneOntologyMolecularFunction	glutamate receptor activity	GRM1 GRM2 GRM3 GRIN3B	6.18e-05	27	161	4	GO:0008066
GeneOntologyMolecularFunction	group II metabotropic glutamate receptor activity	GRM2 GRM3	6.46e-05	2	161	2	GO:0001641
GeneOntologyMolecularFunction	corticotropin-releasing hormone receptor activity	CRHR1 CRHR2	1.93e-04	3	161	2	GO:0043404
GeneOntologyMolecularFunction	corticotrophin-releasing factor receptor activity	CRHR1 CRHR2	1.93e-04	3	161	2	GO:0015056
GeneOntologyBiologicalProcess	synaptic transmission, glutamatergic	MYO5A LRRK2 VPS54 GRM1 GRM2 GRM3 ADRB2 CCL2 GRIN3B	1.01e-06	132	162	9	GO:0035249
GeneOntologyBiologicalProcess	regulation of protein autoubiquitination	LRRK2 MTA1 TAF1	9.35e-06	6	162	3	GO:1902498
GeneOntologyBiologicalProcess	adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway	GRM1 GRM2 GRM3	3.86e-05	9	162	3	GO:0007196
GeneOntologyCellularComponent	axon	CFH MAF1 OPN4 MYO5A DTNA LRRK2 GIT2 GRM1 GRM2 GRM3 AR GFRA1 CRHR2 MADD ADRB2 DST CCL2 TANC1 PLEC IL1R1 KIF1C	5.65e-06	891	162	21	GO:0030424
GeneOntologyCellularComponent	somatodendritic compartment	CFH MAF1 OPN4 MYO5A DTNB SYNE1 LRRK2 CLSTN2 GRM1 GRM2 GRM3 AR GFRA1 CRHR1 CRHR2 ADRB2 MTNR1A KNDC1 CCL2 TANC1 PLEC GRIN3B MOB4 KIF1C SOS1	8.83e-06	1228	162	25	GO:0036477
GeneOntologyCellularComponent	dendrite	MAF1 OPN4 MYO5A DTNB SYNE1 LRRK2 CLSTN2 GRM1 GRM2 GRM3 AR CRHR1 CRHR2 ADRB2 KNDC1 CCL2 TANC1 PLEC MOB4 KIF1C	1.13e-05	858	162	20	GO:0030425
GeneOntologyCellularComponent	dendritic tree	MAF1 OPN4 MYO5A DTNB SYNE1 LRRK2 CLSTN2 GRM1 GRM2 GRM3 AR CRHR1 CRHR2 ADRB2 KNDC1 CCL2 TANC1 PLEC MOB4 KIF1C	1.17e-05	860	162	20	GO:0097447
MousePheno	abnormal Bruch membrane morphology	CFH ABCA4 ABCC6 CCL2	6.65e-06	14	130	4	MP:0005239
Domain	Znf_hrmn_rcpt	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	2.45e-06	46	159	6	IPR001628
Domain	NUCLEAR_REC_DBD_2	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	2.45e-06	46	159	6	PS51030
Domain	NUCLEAR_REC_DBD_1	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	2.45e-06	46	159	6	PS00031
Domain	ZnF_C4	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	2.45e-06	46	159	6	SM00399
Domain	zf-C4	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	2.45e-06	46	159	6	PF00105
Domain	-	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	2.79e-06	47	159	6	1.10.565.10
Domain	Nucl_hrmn_rcpt_lig-bd	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	3.16e-06	48	159	6	IPR000536
Domain	HOLI	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	3.16e-06	48	159	6	SM00430
Domain	Hormone_recep	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	3.16e-06	48	159	6	PF00104
Domain	COUP_TF	NR2F6 NR2F1 NR2F2	5.98e-06	5	159	3	IPR003068
Domain	-	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	8.78e-06	57	159	6	3.30.50.10
Domain	Znf_NHR/GATA	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	9.72e-06	58	159	6	IPR013088
Domain	-	EVPL DST PLEC	1.19e-05	6	159	3	3.90.1290.10
Domain	Peripla_BP_I	GRM1 GRM2 GRM3 GUCY2C GRIN3B	1.91e-05	39	159	5	IPR028082
Domain	Plectin	EVPL DST PLEC	2.07e-05	7	159	3	PF00681
Domain	Plectin_repeat	EVPL DST PLEC	2.07e-05	7	159	3	IPR001101
Domain	PLEC	EVPL DST PLEC	2.07e-05	7	159	3	SM00250
Domain	GPCR_3_mtglu_rcpt	GRM1 GRM2 GRM3	3.29e-05	8	159	3	IPR000162
Domain	ARM-type_fold	DOCK11 UBR4 LRRK2 TEX10 ARMC2 PPP4R4 RANBP17 URB1 PIK3C2G PI4KA HEATR5B TANGO6	3.45e-05	339	159	12	IPR016024
Domain	Nuclear_hrmn_rcpt	NR2C1 NR2C2 NR2F6 NR2F1 NR2F2	4.34e-05	46	159	5	IPR001723
Domain	Distrobrevin	DTNA DTNB	7.20e-05	2	159	2	IPR017432
Domain	Spectrin_repeat	SYNE1 EVPL DST PLEC	1.02e-04	29	159	4	IPR002017
Domain	SPEC	SYNE1 EVPL DST PLEC	1.51e-04	32	159	4	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 EVPL DST PLEC	1.51e-04	32	159	4	IPR018159
Domain	NCD3G	GRM1 GRM2 GRM3	1.63e-04	13	159	3	PF07562
Domain	GPCR_3_9-Cys_dom	GRM1 GRM2 GRM3	1.63e-04	13	159	3	IPR011500
Domain	GPCR_3_CS	GRM1 GRM2 GRM3	2.06e-04	14	159	3	IPR017979
Domain	GPCR_2_CRF_rcpt	CRHR1 CRHR2	2.15e-04	3	159	2	IPR003051
Domain	ANF_lig-bd_rcpt	GRM1 GRM2 GRM3 GUCY2C	2.68e-04	37	159	4	IPR001828
Domain	ANF_receptor	GRM1 GRM2 GRM3 GUCY2C	2.68e-04	37	159	4	PF01094
Domain	RasGEFN	RALGDS KNDC1 SOS1	6.21e-04	20	159	3	SM00229
Domain	RasGEF_N	RALGDS KNDC1 SOS1	7.19e-04	21	159	3	PF00618
Domain	GPCR_3	GRM1 GRM2 GRM3	7.19e-04	21	159	3	IPR000337
Domain	7tm_3	GRM1 GRM2 GRM3	8.28e-04	22	159	3	PF00003
Domain	G_PROTEIN_RECEP_F3_2	GRM1 GRM2 GRM3	8.28e-04	22	159	3	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GRM1 GRM2 GRM3	8.28e-04	22	159	3	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GRM1 GRM2 GRM3	8.28e-04	22	159	3	PS00979
Domain	Ras-like_Gua-exchang_fac_N	RALGDS KNDC1 SOS1	8.28e-04	22	159	3	IPR000651
Domain	G_PROTEIN_RECEP_F3_4	GRM1 GRM2 GRM3	8.28e-04	22	159	3	PS50259
Domain	RASGEF_NTER	RALGDS KNDC1 SOS1	8.28e-04	22	159	3	PS50212
Domain	GPCR_3_C	GRM1 GRM2 GRM3	8.28e-04	22	159	3	IPR017978
Domain	ACTININ_2	SYNE1 DST PLEC	9.46e-04	23	159	3	PS00020
Domain	ACTININ_1	SYNE1 DST PLEC	9.46e-04	23	159	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 DST PLEC	9.46e-04	23	159	3	IPR001589
Domain	EF-hand_dom_typ1	DTNA DTNB	1.06e-03	6	159	2	IPR015153
Domain	EF-hand_dom_typ2	DTNA DTNB	1.06e-03	6	159	2	IPR015154
Domain	EF-hand_2	DTNA DTNB	1.06e-03	6	159	2	PF09068
Domain	EF-hand_3	DTNA DTNB	1.06e-03	6	159	2	PF09069
Domain	RASGEF	RALGDS KNDC1 SOS1	1.36e-03	26	159	3	PS00720
Domain	ZnF_UBR1	UBR4 UBR3	1.47e-03	7	159	2	SM00396
Domain	ZF_UBR	UBR4 UBR3	1.47e-03	7	159	2	PS51157
Domain	zf-UBR	UBR4 UBR3	1.47e-03	7	159	2	PF02207
Domain	Znf_UBR	UBR4 UBR3	1.47e-03	7	159	2	IPR003126
Domain	RASGEF_CAT	RALGDS KNDC1 SOS1	1.88e-03	29	159	3	PS50009
Domain	EPL1	BRPF3 EPC1	1.95e-03	8	159	2	PF10513
Domain	Enhancer_polycomb-like_N	BRPF3 EPC1	1.95e-03	8	159	2	IPR019542
Domain	RasGEF	RALGDS KNDC1 SOS1	2.08e-03	30	159	3	PF00617
Domain	-	RALGDS KNDC1 SOS1	2.08e-03	30	159	3	1.10.840.10
Domain	RASGEF_cat_dom	RALGDS KNDC1 SOS1	2.08e-03	30	159	3	IPR001895
Domain	RasGEF	RALGDS KNDC1 SOS1	2.08e-03	30	159	3	SM00147
Domain	Ras_GEF_dom	RALGDS KNDC1 SOS1	2.08e-03	30	159	3	IPR023578
Domain	PI3Ka	PIK3C2G PI4KA	2.49e-03	9	159	2	PF00613
Domain	PI3Ka	PIK3C2G PI4KA	2.49e-03	9	159	2	SM00145
Domain	DUF3699	GARIN5A GARIN3	2.49e-03	9	159	2	IPR022168
Domain	-	PIK3C2G PI4KA	2.49e-03	9	159	2	1.25.40.70
Domain	DUF3699	GARIN5A GARIN3	2.49e-03	9	159	2	PF12480
Domain	-	LRRK2 TEX10 ARMC2 PPP4R4 RANBP17 HEATR5B TANGO6	2.96e-03	222	159	7	1.25.10.10
Domain	HEAT_REPEAT	TEX10 PPP4R4 HEATR5B TANGO6	3.00e-03	70	159	4	PS50077
Domain	PI_Kinase	PIK3C2G PI4KA	3.10e-03	10	159	2	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3C2G PI4KA	3.10e-03	10	159	2	IPR001263
Domain	PIK_HELICAL	PIK3C2G PI4KA	3.10e-03	10	159	2	PS51545
Domain	PH	PLEKHG4 DOCK11 PREX2 IRS2 PLEKHM3 PLD2 SOS1	3.52e-03	229	159	7	PF00169
Domain	BAH	MTA1 MTA3	3.77e-03	11	159	2	PS51038
Domain	BAH_dom	MTA1 MTA3	3.77e-03	11	159	2	IPR001025
Domain	BAH	MTA1 MTA3	3.77e-03	11	159	2	SM00439
Domain	BAH	MTA1 MTA3	3.77e-03	11	159	2	PF01426
Domain	GDS_CDC24_CS	PLEKHG4 PREX2 SOS1	4.42e-03	39	159	3	IPR001331
Domain	ZnF_GATA	MTA1 MTA3	4.49e-03	12	159	2	SM00401
Domain	ELM2_dom	MTA1 MTA3	5.28e-03	13	159	2	IPR000949
Domain	ELM2	MTA1 MTA3	5.28e-03	13	159	2	PF01448
Domain	ELM2	MTA1 MTA3	5.28e-03	13	159	2	PS51156
Domain	ELM2	MTA1 MTA3	5.28e-03	13	159	2	SM01189
Domain	ABC_transporter_CS	ABCA4 ABCC5 ABCC6	5.45e-03	42	159	3	IPR017871
Domain	VitD_rcpt	NR2C1 NR2C2	6.13e-03	14	159	2	IPR000324
Domain	Ras_G-nucl-exch_fac_CS	RALGDS SOS1	6.13e-03	14	159	2	IPR019804
Domain	PX	PIK3C2G PLD2 SNX11	6.21e-03	44	159	3	SM00312
Domain	-	PLEKHG4 DOCK11 PREX2 PTPN14 RABGAP1L IRS2 PLEKHM3 PLD2 SOS1	6.40e-03	391	159	9	2.30.29.30
Domain	PI3/4_kinase_CS	PIK3C2G PI4KA	7.03e-03	15	159	2	IPR018936
Domain	Znf_GATA	MTA1 MTA3	7.03e-03	15	159	2	IPR000679
Domain	GATA	MTA1 MTA3	7.03e-03	15	159	2	PF00320
Domain	AAA	DNAH3 ABCA4 ABCC5 RFC4 ABCC6	7.83e-03	144	159	5	SM00382
Domain	AAA+_ATPase	DNAH3 ABCA4 ABCC5 RFC4 ABCC6	7.83e-03	144	159	5	IPR003593
Domain	ABC_tran	ABCA4 ABCC5 ABCC6	7.91e-03	48	159	3	PF00005
Domain	ABC_TRANSPORTER_2	ABCA4 ABCC5 ABCC6	7.91e-03	48	159	3	PS50893
Domain	GATA_ZN_FINGER_1	MTA1 MTA3	7.99e-03	16	159	2	PS00344
Domain	-	PIK3C2G PI4KA	7.99e-03	16	159	2	1.10.1070.11
Domain	GATA_ZN_FINGER_2	MTA1 MTA3	7.99e-03	16	159	2	PS50114
Domain	PI3Kc	PIK3C2G PI4KA	7.99e-03	16	159	2	SM00146
Domain	ABC_TRANSPORTER_1	ABCA4 ABCC5 ABCC6	8.38e-03	49	159	3	PS00211
Domain	PX	PIK3C2G PLD2 SNX11	8.38e-03	49	159	3	PF00787
Pathway	WP_NUCLEAR_RECEPTORS	NR2C2 NR2F6 AR NR2F1 NR2F2	1.34e-05	38	115	5	M39657
Pathway	WP_NUCLEAR_RECEPTORS	NR2C2 NR2F6 AR NR2F1 NR2F2	1.34e-05	38	115	5	MM15865
Pathway	WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY	SYNE1 ADCY7 YY1AP1 PLEC SOS1	3.48e-05	46	115	5	M39828
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR2C1 NR2C2 NR2F6 AR NR2F1	4.28e-05	48	115	5	MM14987
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR2C1 NR2C2 NR2F6 AR NR2F1	6.95e-05	53	115	5	M8276
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM1 GRM2 GRM3	2.24e-04	15	115	3	M39442
Pathway	WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE	GRM1 GRM2 GRM3	2.24e-04	15	115	3	MM15845
Pubmed	Graded heterogeneity of metabotropic signaling underlies a continuum of cell-intrinsic temporal responses in unipolar brush cells.	GRM1 GRM2 GRM3	1.05e-07	3	165	3	34620856
Pubmed	The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity.	NR2F6 NR2F1 NR2F2	1.05e-07	3	165	3	18701084
Pubmed	Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor.	NR2C2 NR2F6 NR2F1	1.05e-07	3	165	3	10644740
Pubmed	Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.	GRM1 GRM2 GRM3	4.18e-07	4	165	3	29079293
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	INTU BRPF3 WWC3 SYNE1 BIRC6 CRACD MTA3	6.44e-07	103	165	7	10574462
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TET2 DOCK11 ZNF629 DYRK4 PPP4R4 MADD PTPN14 DST PI4KA DSTYK RABGAP1L IRS2 TANC1 PLEKHM3 PLEC TRAPPC9 KIF1C	8.24e-07	861	165	17	36931259
Pubmed	Cloning and expression during development of three murine members of the COUP family of nuclear orphan receptors.	NR2F6 NR2F1 NR2F2	2.08e-06	6	165	3	7947324
Pubmed	Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q.	GRM1 GRM2 GRM3	2.08e-06	6	165	3	8824806
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CFH TET2 NR2C1 MYO5A SYNE1 UBR4 ABCC5 LMO3 VPS54 LRP1B MADD MTA1 DST MTA3 YY1AP1 TAF1 SGSM3 PLEC USP47 SOS1	3.32e-06	1285	165	20	35914814
Pubmed	A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors.	NR2F6 AR NR2F1 NR2F2	3.34e-06	22	165	4	23975195
Pubmed	Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion.	GRM1 GRM2 GRM3	3.62e-06	7	165	3	9920659
Pubmed	Glutamate can act as a signaling molecule in mouse preimplantation embryos†.	GRM1 GRM2 GRM3 GRIN3B	4.82e-06	24	165	4	35746896
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TET2 NR2C1 NR2C2 UBR4 BIRC6 DST IRS2 TAF1 PLEC ZNF687 TANGO6	5.58e-06	418	165	11	34709266
Pubmed	Tamalin, a PDZ domain-containing protein, links a protein complex formation of group 1 metabotropic glutamate receptors and the guanine nucleotide exchange factor cytohesins.	GRM1 GRM2 GRM3	5.77e-06	8	165	3	11850456
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	IL12RB2 INTU BRPF3 POLR2B ZNF629 CLSTN2 RFC4 PTPN14 MTA1 MTA3 CIBAR1 EPC1 SUPT16H IRS2 TANC1 TAF1 ZNF687 SOS1	6.57e-06	1116	165	18	31753913
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MYO5A DTNA DTNB POLR2B TEX10 BIRC6 PPP4R4 MADD PTPN14 PTPRG WDR11 PI4KA SUPT16H UBR3 TANC1 UTP3 AJUBA	1.13e-05	1049	165	17	27880917
Pubmed	Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors.	GRM1 GRM2 GRM3	1.23e-05	10	165	3	9069281
Pubmed	Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase.	NR2C1 NR2C2 AR	1.68e-05	11	165	3	12943985
Pubmed	Genetic variation associated with preterm birth: a HuGE review.	ADRB2 IL1R1 IL4	1.68e-05	11	165	3	16301860
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA3F NR2F6 UBR4 BIRC6 ADCY7 NR2F2 MADD URB1 DST PI4KA IRS2 TANC1 PLEC SNX11 TRAPPC9 ZNF687 MVB12B	2.20e-05	1105	165	17	35748872
Pubmed	A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread.	IL12RB2 IL1R1 IL4	2.24e-05	12	165	3	22980983
Pubmed	Selective silencing of individual dendritic branches by an mGlu2-activated potassium conductance in dentate gyrus granule cells.	GRM2 GRM3	2.24e-05	2	165	2	23616537
Pubmed	Assignment to chromosome 11 of mouse p68 RNA helicase gene (Hlr1) and pseudogene (Hlr1-ps1).	DDX5 IL4	2.24e-05	2	165	2	7729546
Pubmed	Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling.	CRHR1 CRHR2	2.24e-05	2	165	2	19098121
Pubmed	Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome.	CRHR1 CRHR2	2.24e-05	2	165	2	37543650
Pubmed	The effect of local IL-4 delivery or CCL2 blockade on implant fixation and bone structural properties in a mouse model of wear particle induced osteolysis.	CCL2 IL4	2.24e-05	2	165	2	27114284
Pubmed	Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.	CFH CFHR1	2.24e-05	2	165	2	22136554
Pubmed	The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.	GRM2 GRM3	2.24e-05	2	165	2	17670976
Pubmed	Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1.	CFH CFHR1	2.24e-05	2	165	2	18824548
Pubmed	Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis.	GRM3 USP47	2.24e-05	2	165	2	31925813
Pubmed	NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.	GRM2 GRM3	2.24e-05	2	165	2	28285415
Pubmed	Genetic variation in the corticotrophin-releasing factor receptors: identification of single-nucleotide polymorphisms and association studies with obesity in UK Caucasians.	CRHR1 CRHR2	2.24e-05	2	165	2	14724656
Pubmed	Localization of transcripts of the related nuclear orphan receptors COUP-TF I and ARP-1 in the adult mouse brain.	NR2F1 NR2F2	2.24e-05	2	165	2	7609634
Pubmed	Cloning of the 1.4-kb mRNA species of human complement factor H reveals a novel member of the short consensus repeat family related to the carboxy terminal of the classical 150-kDa molecule.	CFH CFHR1	2.24e-05	2	165	2	1826708
Pubmed	Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.	GRM2 GRM3	2.24e-05	2	165	2	22089319
Pubmed	Regulation of cocaine-induced reinstatement by group II metabotropic glutamate receptors in the ventral tegmental area.	GRM2 GRM3	2.24e-05	2	165	2	21881873
Pubmed	Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition.	GRM2 GRM3	2.24e-05	2	165	2	21832989
Pubmed	Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.	CXCL16 CCL2	2.24e-05	2	165	2	24388986
Pubmed	Effect of CRHR1 and CRHR2 gene polymorphisms and childhood trauma in suicide attempt.	CRHR1 CRHR2	2.24e-05	2	165	2	30874897
Pubmed	The role of group II metabotropic glutamate receptors in cognition and anxiety: comparative studies in GRM2(-/-), GRM3(-/-) and GRM2/3(-/-) knockout mice.	GRM2 GRM3	2.24e-05	2	165	2	25158312
Pubmed	Metabotropic glutamate receptor 2/3 in the hippocampus of patients with mesial temporal lobe epilepsy, and of rats and mice after pilocarpine-induced status epilepticus.	GRM2 GRM3	2.24e-05	2	165	2	15246118
Pubmed	Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia.	GRM2 GRM3	2.24e-05	2	165	2	18853337
Pubmed	TET2 binds the androgen receptor and loss is associated with prostate cancer.	TET2 AR	2.24e-05	2	165	2	27819678
Pubmed	Hippocampal mossy fiber long-term depression in Grm2/3 double knockout mice.	GRM2 GRM3	2.24e-05	2	165	2	21360593
Pubmed	Expression of metabotropic glutamate receptor mRNAs in the human spinal cord: implications for selective vulnerability of spinal motor neurons in amyotrophic lateral sclerosis.	GRM1 GRM3	2.24e-05	2	165	2	11535235
Pubmed	A novel nuclear receptor heterodimerization pathway mediated by orphan receptors TR2 and TR4.	NR2C1 NR2C2	2.24e-05	2	165	2	9737983
Pubmed	Activation of metabotropic glutamate receptor type 2/3 supports the involvement of the hippocampal mossy fiber pathway on contextual fear memory consolidation.	GRM2 GRM3	2.24e-05	2	165	2	19638469
Pubmed	Enhancement of CA3 hippocampal network activity by activation of group II metabotropic glutamate receptors.	GRM2 GRM3	2.24e-05	2	165	2	21628565
Pubmed	Expression and subcellular localization of CRH and its receptors in human endometrial cancer.	CRHR1 CRHR2	2.24e-05	2	165	2	19433256
Pubmed	TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.	NR2C1 AR	2.24e-05	2	165	2	12949936
Pubmed	Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice.	GRM2 GRM3	2.24e-05	2	165	2	24053122
Pubmed	Glial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis.	GRM1 GRM2	2.24e-05	2	165	2	15330338
Pubmed	Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice.	GRM2 GRM3	2.24e-05	2	165	2	38969501
Pubmed	Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.	GRM2 GRM3	2.24e-05	2	165	2	25583490
Pubmed	Interaction between complement regulators and Streptococcus pyogenes: binding of C4b-binding protein and factor H/factor H-like protein 1 to M18 strains involves two different cell surface molecules.	CFH CFHR1	2.24e-05	2	165	2	15557185
Pubmed	Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.	CFH CFHR1	2.24e-05	2	165	2	21677636
Pubmed	An evolutionary conserved COUP-TF binding element in a neural-specific gene and COUP-TF expression patterns support a major role for COUP-TF in neural development.	NR2F1 NR2F2	2.24e-05	2	165	2	7708064
Pubmed	The mGluR2/3 agonist LY379268 induced anti-reinstatement effects in rats exhibiting addiction-like behavior.	GRM2 GRM3	2.24e-05	2	165	2	23624743
Pubmed	Deletion of Metabotropic Glutamate Receptors 2 and 3 (mGlu2 & mGlu3) in Mice Disrupts Sleep and Wheel-Running Activity, and Increases the Sensitivity of the Circadian System to Light.	GRM2 GRM3	2.24e-05	2	165	2	25950516
Pubmed	Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.	GRM2 GRM3	2.24e-05	2	165	2	19386277
Pubmed	The metabotropic glutamate receptor types 2/3 inhibit L-type calcium channels via a pertussis toxin-sensitive G-protein in cultured cerebellar granule cells.	GRM2 GRM3	2.24e-05	2	165	2	7965099
Pubmed	Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway.	GRM2 GRM3	2.24e-05	2	165	2	24080311
Pubmed	Spatiotemporal expression patterns of chicken ovalbumin upstream promoter-transcription factors in the developing mouse central nervous system: evidence for a role in segmental patterning of the diencephalon.	NR2F1 NR2F2	2.24e-05	2	165	2	8183930
Pubmed	Androgen-androgen receptor system improves chronic inflammatory conditions by suppressing monocyte chemoattractant protein-1 gene expression in adipocytes via transcriptional regulation.	AR CCL2	2.24e-05	2	165	2	27392713
Pubmed	Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.	CFH CFHR1	2.24e-05	2	165	2	22894814
Pubmed	Dynamic expression of COUP-TFI and COUP-TFII during development and functional maturation of the mouse inner ear.	NR2F1 NR2F2	2.24e-05	2	165	2	15907456
Pubmed	ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum.	ABCA4 ABCC6	2.24e-05	2	165	2	12673275
Pubmed	The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain.	CRHR1 CRHR2	2.24e-05	2	165	2	12110614
Pubmed	Distinct distribution of corticotropin releasing factor receptors in human breast cancer.	CRHR1 CRHR2	2.24e-05	2	165	2	20630588
Pubmed	System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury.	GRM1 IL1R1	2.24e-05	2	165	2	17881516
Pubmed	Activation of both Group I and Group II metabotropic glutamatergic receptors suppress retinogeniculate transmission.	GRM1 GRM2	2.24e-05	2	165	2	23558090
Pubmed	The Transcription Factors COUP-TFI and COUP-TFII have Distinct Roles in Arealisation and GABAergic Interneuron Specification in the Early Human Fetal Telencephalon.	NR2F1 NR2F2	2.24e-05	2	165	2	28922831
Pubmed	Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors.	GRM2 GRM3	2.24e-05	2	165	2	27911756
Pubmed	Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.	GRM2 GRM3	2.24e-05	2	165	2	23392308
Pubmed	Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice.	GRM2 GRM3	2.24e-05	2	165	2	20970439
Pubmed	Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos.	PLD2 SOS1	2.24e-05	2	165	2	17486115
Pubmed	Expression of the Abca-subfamily of genes in Abcc6-/- mice--upregulation of Abca4.	ABCA4 ABCC6	2.24e-05	2	165	2	21435020
Pubmed	Behavioural and biochemical responses to methamphetamine are differentially regulated by mGlu2 and mGlu3 metabotropic glutamate receptors in male mice.	GRM2 GRM3	2.24e-05	2	165	2	34217776
Pubmed	Association between corticotropin-releasing hormone receptor 1 and 2 (CRHR1 and CRHR2) gene polymorphisms and personality traits.	CRHR1 CRHR2	2.24e-05	2	165	2	23982282
Pubmed	Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells.	CRHR1 CRHR2	2.24e-05	2	165	2	16721033
Pubmed	COUP-TFI and -TFII nuclear receptors are expressed in amacrine cells and play roles in regulating the differentiation of retinal progenitor cells.	NR2F1 NR2F2	2.24e-05	2	165	2	19766631
Pubmed	Group II metabotropic glutamate receptor blockade promotes stress resilience in mice.	GRM2 GRM3	2.24e-05	2	165	2	30939596
Pubmed	Pro-atherogenic effect of interleukin-4 in endothelial cells: modulation of oxidative stress, nitric oxide and monocyte chemoattractant protein-1 expression.	CCL2 IL4	2.24e-05	2	165	2	16249002
Pubmed	Novel NR2F1 variants likely disrupt DNA binding: molecular modeling in two cases, review of published cases, genotype-phenotype correlation, and phenotypic expansion of the Bosch-Boonstra-Schaaf optic atrophy syndrome.	NR2F1 NR2F2	2.24e-05	2	165	2	28963436
Pubmed	The effect of mGlu2/3 receptors on synaptic activities to different types of GABAergic interneurons in the anterior cingulate cortex.	GRM2 GRM3	2.24e-05	2	165	2	32525061
Pubmed	Expression and subcellular distribution of glutamate receptor subunits 2/3 in the developing cerebellar cortex.	GRM2 GRM3	2.24e-05	2	165	2	8838577
Pubmed	Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.	NR2C1 NR2C2	2.24e-05	2	165	2	22042865
Pubmed	Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice.	GRM2 GRM3	2.24e-05	2	165	2	34330748
Pubmed	A bidirectional regulation between the TR2/TR4 orphan receptors (TR2/TR4) and the ciliary neurotrophic factor (CNTF) signaling pathway.	NR2C1 NR2C2	2.24e-05	2	165	2	9694834
Pubmed	Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.	GRM2 GRM3	2.24e-05	2	165	2	25434487
Pubmed	mGlu2/3 receptor in the prelimbic cortex is implicated in stress resilience and vulnerability in mice.	GRM2 GRM3	2.24e-05	2	165	2	34090896
Pubmed	Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS.	CFH CFHR1	2.24e-05	2	165	2	20865640
Pubmed	A synthetic protein as efficient multitarget regulator against complement over-activation.	CFH CFHR1	2.24e-05	2	165	2	35194132
Pubmed	Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.	CFH CFHR1	2.24e-05	2	165	2	23243267
Pubmed	Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other.	NR2F6 NR2F1	2.24e-05	2	165	2	2905047
Pubmed	Expression of corticotropin-releasing hormone receptor type 1 and type 2 in human pregnant myometrium.	CRHR1 CRHR2	2.24e-05	2	165	2	17959885
Pubmed	Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts.	CRHR1 CRHR2	2.24e-05	2	165	2	18325997
Pubmed	Different effects of chronic social defeat on social behavior and the brain CRF system in adult male C57 mice with different susceptibilities.	CRHR1 CRHR2	2.24e-05	2	165	2	32057826
Pubmed	The chicken ovalbumin upstream promoter-transcription factor II negatively regulates the transactivation of androgen receptor in prostate cancer cells.	AR NR2F2	2.24e-05	2	165	2	23145053
Pubmed	Human complement factor H and factor H-like protein 1 are expressed in human retinal pigment epithelial cells.	CFH CFHR1	2.24e-05	2	165	2	24280833
Interaction	PI4KAP2 interactions	APPBP2 PI4KAP2 PI4KA	4.85e-06	5	160	3	int:PI4KAP2
GeneFamily	Nuclear hormone receptors	NR2C1 NR2C2 NR2F6 AR NR2F1 NR2F2	7.56e-07	49	118	6	71
GeneFamily	EF-hand domain containing\|Plakins	EVPL DST PLEC	1.48e-05	8	118	3	939
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM1 GRM2 GRM3	1.48e-05	8	118	3	281
GeneFamily	Corticotropin releasing hormone receptors	CRHR1 CRHR2	4.22e-05	2	118	2	266
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR4 UBR3	8.68e-04	7	118	2	785
GeneFamily	PHD finger proteins\|NuRD complex	MTA1 MTA3	2.67e-03	12	118	2	1305
GeneFamily	ATP binding cassette subfamily C	ABCC5 ABCC6	3.14e-03	13	118	2	807
GeneFamily	Chemokine ligands\|Endogenous ligands	CXCL16 CCL2 CCL24	3.15e-03	45	118	3	483
GeneFamily	Trafficking protein particle complex	TRAPPC10 TRAPPC9	3.65e-03	14	118	2	772
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MTA1 MTA3	4.20e-03	15	118	2	82
Coexpression	DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS	GPR85 LMO3 PI4KAP2 GRM1 GRM2 GRM3 LRP1B	8.21e-06	115	164	7	M40201
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	SEMA3F MAF1 RALGDS VPS54 MADD TAF1 SGSM3 SNX11	1.52e-05	175	164	8	M34029
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	APPBP2 DTNA SYNE1 ACOX1 DYRK4 DST FSCN2 CCL2 SGSM3 PLEC	1.54e-05	290	164	10	M13251
Coexpression	KRAS.DF.V1_DN	PGLYRP4 SYNE1 FANCE URB1 PTPN14 ADRB2 CLDN17 TRAPPC10	3.06e-05	193	164	8	M2861
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD TRANK1 TANC1	4.80e-08	194	165	9	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD TRANK1 TANC1	4.80e-08	194	165	9	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH ADAMTSL1 SYNE1 LRRK2 CLSTN2 CPED1 PREX2 GFRA1 PTPRG	6.23e-08	200	165	9	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RDH14 UNC13D ELFN2 FBXO47 GFRA1 CRHR1 SPATS2L CCL2	1.33e-07	157	165	8	beab0ac47202266b04543c02cfcdda012375e879
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NUGGC DOCK11 GRM1 NR2F2 CRHR2 CRACD SPATS2L TANC1	5.92e-07	191	165	8	de54dab85db70f847de75b3b6d7667a0e13b9bfb
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH CFHR1 CLSTN2 NR2F2 PTPRG CCL2 ECEL1 KCNT1	7.76e-07	198	165	8	dc6d9032c5029527e184ac13b887c0c1f22ef1c0
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	FNDC3B DTNB VPS54 BIRC6 RABGAP1L UBR3 TRAPPC9 SOS1	8.06e-07	199	165	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH SYNE1 LRRK2 CPED1 NR2F1 PREX2 GFRA1 PTPRG	8.37e-07	200	165	8	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR85 GRM2 ELFN2 CRHR1 TRANK1 KNDC1 KCNT1	1.13e-06	144	165	7	e9d62f202f0fa8747961036ef0eafed91fe8a42f
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRM1 NR2F2 CRHR2 PPP4R4 TIMELESS ECEL1 MGAT4C	1.36e-06	148	165	7	4d43efee96a6493abd78e9ca41aab73db0c80626
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRM1 NR2F2 CRHR2 TIMELESS ECEL1 MGAT4C	1.67e-06	97	165	6	f3c3fb260954f594a9ab8e1ac9a01115767cbc7a
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	CFH DOCK11 DTNA SYNE1 GFRA1 IL1R1 MGAT4C	3.69e-06	172	165	7	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CFH SYNE1 GFRA1 NR2F2 DST IL1R1 MGAT4C	4.80e-06	179	165	7	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC3B ABCA4 WWC3 DTNA PPP4R4 PTPN14 GRIN3B	5.55e-06	183	165	7	83592c332b1e82673f993d37c7f480befdc3dcda
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	MYO5A DOCK11 CLSTN2 AR PREX2 PTPRG DSTYK	5.75e-06	184	165	7	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CPED1 NR2F1 GFRA1 CRACD MGAT4C	5.75e-06	184	165	7	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD IL1R1	6.40e-06	187	165	7	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CPED1 NR2F1 GFRA1 NR2F2 CRACD TANC1	6.86e-06	189	165	7	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CPED1 NR2F1 GFRA1 NR2F2 CRACD TANC1	6.86e-06	189	165	7	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 SYNE1 CPED1 URB1 CCL2 IL1R1 MGAT4C	7.10e-06	190	165	7	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 SYNE1 CPED1 URB1 CCL2 IL1R1 MGAT4C	7.10e-06	190	165	7	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CLSTN2 CPED1 NR2F1 GFRA1 CRACD	7.34e-06	191	165	7	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CPED1 NR2F1 GFRA1 NR2F2 CRACD TANC1	7.34e-06	191	165	7	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CLSTN2 CPED1 NR2F1 GFRA1 CRACD	7.34e-06	191	165	7	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CPED1 NR2F1 GFRA1 NR2F2 CRACD TANC1	7.34e-06	191	165	7	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD	7.60e-06	192	165	7	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD	7.60e-06	192	165	7	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	CFH NR2F1 GFRA1 CRACD DST PTPRG IL1R1	7.86e-06	193	165	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADAMTSL1 ABCA4 GRM2 F2RL2 NR2F1 PREX2 NR2F2	8.13e-06	194	165	7	8a4be91414a2e69dd410aa75791f16008204c9a1
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 UBR4 LRRK2 CXCL16 CLSTN2 GFRA1 CCL2	8.13e-06	194	165	7	70185c0b8e0f4e896645b17a243482ba3cdf4a5d
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD IL1R1	8.41e-06	195	165	7	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH NR2F1 PTPRG CIBAR1 CCL2 TANC1 IL1R1	8.69e-06	196	165	7	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CPED1 NR2F1 GFRA1 NR2F2 CRACD TANC1	8.98e-06	197	165	7	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CPED1 NR2F1 GFRA1 NR2F2 CRACD TANC1	8.98e-06	197	165	7	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 SYNE1 CPED1 NR2F1 PREX2 CCL2 IL1R1	8.98e-06	197	165	7	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 SYNE1 CPED1 NR2F1 PREX2 CCL2 IL1R1	9.28e-06	198	165	7	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRM1 ADCY7 NR2F2 CRHR2 ECEL1 MGAT4C	9.51e-06	131	165	6	3cb4b272e28ee9bad6d874f64a7aae18352a6cfb
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CFH CFHR1 CLSTN2 NR2F1 GFRA1 NR2F2 CRACD	9.59e-06	199	165	7	0cdbedf09ec72734b86ddab3fec562e066afed92
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH SYNE1 CLSTN2 GFRA1 NR2F2 CCL2 MGAT4C	9.59e-06	199	165	7	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH SYNE1 CLSTN2 GFRA1 NR2F2 CCL2 MGAT4C	9.59e-06	199	165	7	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	CFH CPED1 NR2F1 GFRA1 NR2F2 DST IL1R1	9.59e-06	199	165	7	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH SYNE1 CPED1 NR2F1 PREX2 GFRA1 PTPRG	9.91e-06	200	165	7	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	SEMA3F FNDC3B LRP1B PREX2 NR2F2 PLEC IL1R1	9.91e-06	200	165	7	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CFH SYNE1 CPED1 NR2F1 PREX2 GFRA1 CCL2	9.91e-06	200	165	7	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFH EVPL TMEM121 PPP4R4 SLC5A8 TRBC1	1.83e-05	147	165	6	5e6dd2ddc67b3722f6528e7277cbc7f296098687
ToppCell	10x5'-Liver-Myeloid_Mac-Intestinal_macrophages\|Liver / Manually curated celltypes from each tissue	INTU ABCC5 LRP1B DST KNDC1 CCL2	2.56e-05	156	165	6	9a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell	facs-Marrow-B-cells-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH GPR85 CXCL16 CCL2 CCL24 KCNT1	2.66e-05	157	165	6	0966e347f8d32b13f8a3b3afba3f64637c69cdf9
ToppCell	facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH GPR85 CXCL16 CCL2 CCL24 KCNT1	2.66e-05	157	165	6	6ebfedd91d62c6d4aa8f046657a899a279f82ba2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD	2.85e-05	159	165	6	e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2 CRACD	2.85e-05	159	165	6	2607b562903228274fbd96168ba826782fab0b53
ToppCell	Influenza_Severe-gd_T\|World / Disease group and Cell class	NUGGC SYNE1 ELFN2 PRG2 TRBC2 MGAT4C	3.06e-05	161	165	6	b3cdaed4d58d57e3c5dbc904a09388f3bf949407
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CFH TMEM121 PIK3C2G MINAR1 TRBC2 TRBC1	3.39e-05	164	165	6	8f3255d7f67890389a768453492243ea982eb38a
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GRM1 ADCY7 CRHR2 ECEL1 FBXO39	3.72e-05	101	165	5	cf52c93f523c5f25bd45519a1444ce7bd1d8b577
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CPED1 NR2F1 GFRA1 CRACD	3.88e-05	168	165	6	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 DOCK11 LRRK2 CLSTN2 PREX2 PTPN14	4.15e-05	170	165	6	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CLSTN2 NR2F1 PREX2 NR2F2 GRIN3B AJUBA	4.57e-05	173	165	6	f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a
ToppCell	PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CLSTN2 NR2F1 PREX2 NR2F2 GRIN3B AJUBA	4.57e-05	173	165	6	cbd65dd5b01cc959e3ccbc89330ddd0122296ea3
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH ADAMTSL1 NR2F1 GFRA1 PTPRG TANC1	4.72e-05	174	165	6	f90ca117b729436cf452e2ddcec26ba525c5c13b
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A DTNA LMO3 ADRB2 RFLNB ECEL1	4.72e-05	174	165	6	8bdf5a97faf1cf0426d1a8851f8a3e27578f7598
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 DTNA TMEM121 PPP4R4 PTPN14 GRIN3B	4.72e-05	174	165	6	46bd0ef7d0541386de7a901d85d53d0176dc92bf
ToppCell	facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A DTNA LMO3 ADRB2 RFLNB ECEL1	4.72e-05	174	165	6	fbf998dd33ac27dad7639ea85fca393ba2835307
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SEMA3F ADAMTSL1 PLEKHG4 NR2F2 PTPN14 DUOXA2	5.03e-05	176	165	6	460cb302c5b3d609c65b924e1d4e8ea057a68485
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EVPL DYRK4 ELFN2 GFRA1 TMEM121 MTA3	5.03e-05	176	165	6	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PKD1L3 NR2F1 NR2F2 PTPN14 DST MGAT4C	5.36e-05	178	165	6	ad3de3e03a401dac64431a541899445262246347
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH ADAMTSL1 CPED1 NR2F1 GFRA1 NR2F2	5.36e-05	178	165	6	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	SYNE1 LRRK2 LMO3 PPP4R4 PTPRG SLC5A8	5.70e-05	180	165	6	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	MatrixFB-Fibroblast-A\|MatrixFB / shred on cell class and cell subclass (v4)	CFH CPED1 PREX2 NR2F2 PPP4R4 SPATS2L	5.70e-05	180	165	6	adc64ad6033af705dd7b9163a83e20ef5c59f6eb
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SEMA3F PGLYRP4 EVPL NR2F2 SLC5A8 DUOXA2	5.88e-05	181	165	6	faff2a34e391d053a17c926540e6cb46d94dd629
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SEMA3F PGLYRP4 EVPL NR2F2 SLC5A8 DUOXA2	5.88e-05	181	165	6	5a9c332c0bf07cc20eaf8cf77b45e73668a6467d
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SEMA3F PGLYRP4 EVPL NR2F2 SLC5A8 DUOXA2	5.88e-05	181	165	6	488a517f6e5543b648a2e72e0e04332fad776de6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 DOCK11 LRRK2 CLSTN2 PTPN14 PTPRG	5.88e-05	181	165	6	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFH NUGGC DTNA CLSTN2 GFRA1 DST	5.88e-05	181	165	6	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SEMA3F PGLYRP4 EVPL NR2F2 SLC5A8 DUOXA2	5.88e-05	181	165	6	58651853f9c715075889856793df66ebe00c04f1
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH DOCK11 DTNA SYNE1 IL1R1 MGAT4C	5.88e-05	181	165	6	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CFH DOCK11 DTNA SYNE1 IL1R1 MGAT4C	5.88e-05	181	165	6	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SEMA3F F2RL2 NR2F1 PREX2 NR2F2 SSUH2	6.06e-05	182	165	6	997d37ca2af661c92a56add888762724dfccc890
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA4 DOCK11 LRRK2 CLSTN2 PTPN14 PTPRG	6.06e-05	182	165	6	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADCY7 NR2F2 PPP4R4 MTNR1A MGAT4C	6.37e-05	113	165	5	feb3c6a7723263d58e5ce020a0097fedfcf78ca8
ToppCell	droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CFHR1 PREX2 NR2F2 C17orf58 PIK3C2G	6.44e-05	184	165	6	89ac32e374a4379e4a6c6ea7603b1378b77c147f
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DTNA CLSTN2 NR2F1 NR2F2 CRHR2 AJUBA	6.44e-05	184	165	6	55dde9c4eebac2a33788c1ff1d8fe312d150fad4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CFH CPED1 NR2F1 GFRA1 CRACD TANC1	6.44e-05	184	165	6	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DTNA CLSTN2 NR2F1 NR2F2 CRHR2 AJUBA	6.44e-05	184	165	6	7128a2be291544d3df3ed6c80f21ddda8437dcba
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DTNA CLSTN2 NR2F1 NR2F2 CRHR2 AJUBA	6.44e-05	184	165	6	d14238f7b0b55a4c8d7040bea854bd221a66ac30
ToppCell	droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH CFHR1 PREX2 NR2F2 C17orf58 PIK3C2G	6.44e-05	184	165	6	4df6027fa635996c1eddb920f88a5265772df1cd
ToppCell	Control-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	TET2 IL12RB2 VPS54 SPATS2L TRBC2 IL1R1	6.63e-05	185	165	6	e481cacda0b6b25f5f0062b962df9a442053ac30
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	LRRK2 LMO3 RANBP17 PTPRG TANC1 SLC5A8	6.83e-05	186	165	6	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 DTNA LRRK2 ABCC6 SPATS2L SLC5A8	6.83e-05	186	165	6	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DTNA F2RL2 CPED1 PREX2 RFLNB TRBC2	6.83e-05	186	165	6	cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCell	droplet-Lung-nan-18m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGDS NR2F6 ACOX1 ABCC5 CRACD DST	7.04e-05	187	165	6	f0c6e53035b00772377c4d5f761b4d11026b911a
ToppCell	droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RALGDS NR2F6 ACOX1 ABCC5 CRACD DST	7.04e-05	187	165	6	f20e7a1751694390f535ffb27b97e887220f8695
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	CFH NR2F1 GFRA1 CRACD DST PTPRG	7.04e-05	187	165	6	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH DOCK11 SYNE1 CLSTN2 CCL2 MGAT4C	7.25e-05	188	165	6	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADAMTSL1 LRRK2 LMO3 EVPL ABCC6 ADCY7	7.25e-05	188	165	6	0d86044bc340e3efb90d0022dd299873639d831c
ToppCell	CF-Lymphoid-T_cell_&_NK_cell\|Lymphoid / Disease state, Lineage and Cell class	IL12RB2 SPATS2L TRBC2 TRBC1 LINC02694 MVB12B	7.25e-05	188	165	6	15057036b46c9df621ec4955aa94ca3036245d45
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFH DOCK11 SYNE1 CLSTN2 CCL2 MGAT4C	7.25e-05	188	165	6	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CFH CLSTN2 F2RL2 CPED1 PREX2 IL1R1	7.25e-05	188	165	6	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK11 DTNA LRRK2 CLSTN2 AR SPATS2L	7.46e-05	189	165	6	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	droplet-Heart-HEART-1m-Endothelial-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLEKHG4 SSUH2 RFLNB PRDM14 ITPRIPL1 DUOXA2	7.46e-05	189	165	6	4225bbff4037eecc93a12abad3a38dd04b1e22be
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	CFH ADRB2 DST TANC1 IL1R1 MVB12B	7.68e-05	190	165	6	0c7eb8f4f2926af01bf44d5c9f239be7b81c67fe
ToppCell	MS-CD8-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	CFH USP18 POLR2B MTA1 SPATS2L ITPRIPL1	7.68e-05	190	165	6	8c831c4560b8e70f92b4c15644fea39f7f7afcf2
Drug	Mspg	GRM1 GRM2 GRM3 MTNR1A	1.81e-06	13	165	4	CID003964410
Drug	AC1NSKBB	GRM1 GRM2 GRM3 TAF1	1.81e-06	13	165	4	CID005311256
Drug	CDRI-85/287	NR2C2 NR2F6 AR NR2F1 NR2F2	1.94e-06	29	165	5	CID000159508
Drug	AC1L1EKQ	GRM1 GRM2 GRM3 ADCY7 ADRB2 GRIN3B	2.04e-06	52	165	6	CID000002834
Drug	NPC 12626	GRM1 GRM2 GRM3 AR GRIN3B	2.74e-06	31	165	5	CID000108099
Drug	sodium molybdate	NR2C2 NR2F6 AR NR2F1 NR2F2 PRG2	3.53e-06	57	165	6	CID000061424
Drug	Acamprosate	GRM1 GRM2 GRM3	3.70e-06	5	165	3	DB00659
Drug	1-aminoindan-1,5-dicarboxylic acid	GRM1 GRM2 GRM3 PLD2 GRIN3B	3.79e-06	33	165	5	CID000002071
Drug	3,5-dihydroxyphenylglycine	GRM1 GRM2 GRM3 TAF1 PLD2 GRIN3B	4.79e-06	60	165	6	CID000108001
Drug	mono-(2-ethylhexyl)phthalate	ABCA4 ACOX1 UNC13D AR ABCC6 ADCY7 NR2F2 CRHR2 RANBP17 DST PIK3C2G KNDC1 CCL2 IRS2 TAF1 GRIN3B AJUBA	6.26e-06	658	165	17	ctd:C016599
Drug	4CPG	GRM1 GRM2 GRM3 TAF1 GRIN3B	7.78e-06	38	165	5	CID000005115
Drug	17alpha-estradiol	NR2C2 NR2F6 ACOX1 ABCC5 GRM1 GRM2 GRM3 LRP1B AR ADCY7 NR2F1 GFRA1 NR2F2 MTA1 MTA3 PTPRG PIK3C2G GUCY2C CCL2 IRS2 PLEC GRIN3B IL1R1 IL4 KCNT1	7.90e-06	1303	165	25	CID000000450
Drug	aminocyclopentane	GRM1 GRM2 GRM3 MTNR1A	9.47e-06	19	165	4	CID000002906
Drug	azetidine-2,4-dicarboxylic acid	GRM1 GRM2 GRM3	1.28e-05	7	165	3	CID000005370
Drug	E-guggulsterone	NR2C2 NR2F6 INTU GPR85 AR NR2F1 NR2F2	1.39e-05	108	165	7	CID006439929
Drug	Lisinopril [83915-83-7]; Down 200; 9uM; MCF7; HT_HG-U133A	NR2C1 NR2C2 DTNA ZSCAN9 EVPL URB1 SGSM3 PLD2 KIF1C	1.54e-05	199	165	9	7403_DN
Drug	acamprosate	GRM1 GRM2 GRM3 CRHR1 TIMELESS GRIN3B	1.63e-05	74	165	6	CID000071158
Drug	dopamine	NR2C2 NR2F6 LRRK2 GRM1 GRM2 GRM3 AR ADCY7 NR2F1 GFRA1 NR2F2 ADRB2 GUCY2C MTNR1A TIMELESS PLD2 GRIN3B	1.83e-05	715	165	17	CID000000681
Drug	cis-MCG-I	GRM1 GRM2 GRM3	2.04e-05	8	165	3	CID003035584
Drug	MSOP	GRM1 GRM2 GRM3 MTNR1A	2.11e-05	23	165	4	CID003964633
Drug	YM90K	GRM1 GRM2 GRM3 GRIN3B	2.11e-05	23	165	4	CID005486547
Drug	Implanon	NR2C2 NR2F6 AR NR2F1 NR2F2	2.26e-05	47	165	5	CID000040976
Drug	CGP 39653	GRM1 GRM2 GRM3 GRIN3B	2.52e-05	24	165	4	CID006437837
Drug	RS)-2-chloro-5-hydroxyphenylglycine	GRM1 GRM2 GRM3 GRIN3B	2.52e-05	24	165	4	CID003645780
Drug	methylenecyclopropylglycine	GRM1 GRM2 GRM3 TAF1 GRIN3B	2.77e-05	49	165	5	CID000441452
Drug	5,7-dichlorokynurenic acid	INTU GRM1 GRM2 GRM3 GRIN3B	2.77e-05	49	165	5	CID000001779
Drug	plakin	PLEKHG4 SYNE1 EVPL DST PLEC MGAT4C	2.94e-05	82	165	6	CID000018752
Drug	AC1L1D63	GRM1 GRM2 GRM3 TAF1	2.99e-05	25	165	4	CID000002209
Drug	gavestinel	GRM1 GRM2 GRM3 GRIN3B	2.99e-05	25	165	4	CID006450546
Drug	mM PEP	GRM1 GRM2 GRM3	3.04e-05	9	165	3	CID005311462
Drug	AC1N21PP	GRM1 GRM2 GRM3	3.04e-05	9	165	3	CID004014619
Drug	1,3-cyclopentanedicarboxylic acid	GRM1 GRM2 GRM3	3.04e-05	9	165	3	CID000107216
Drug	L-CCG-I	GRM1 GRM2 GRM3 TAF1 GRIN3B	3.06e-05	50	165	5	CID000001271
Drug	AC1L9LMC	INTU MYO5A DTNA SYNE1 DST PLEC	3.15e-05	83	165	6	CID000448113
Drug	LY354740	GRM1 GRM2 GRM3 TAF1 GRIN3B	3.38e-05	51	165	5	CID000114827
Drug	AC1NQH9B	GRM1 GRM2 GRM3 GRIN3B	3.51e-05	26	165	4	CID005221504
Drug	N-Ac-D-E	SYNE1 GRM1 GRM2 GRM3 GRIN3B	4.08e-05	53	165	5	CID000005255
Drug	L-689,560	GRM1 GRM2 GRM3 GRIN3B	4.10e-05	27	165	4	CID000121918
Drug	NS-105	GRM1 GRM2 GRM3	4.32e-05	10	165	3	CID000198695
Drug	C-PP	GRM1 GRM2 GRM3 GRIN3B	4.75e-05	28	165	4	CID000001228
Drug	aptiganel	GRM1 GRM2 GRM3 GRIN3B	4.75e-05	28	165	4	CID000060839
Drug	AC1Q6PCP	NR2C2 NR2F6 AR ABCC6 NR2F1 NR2F2 DST CCL2 PLEC	4.79e-05	230	165	9	CID000005267
Drug	Cyclopentanes	AR IL4	5.22e-05	2	165	2	ctd:D003517
Drug	phenylalanyl corticotropin-releasing factor (12-41)	CRHR1 CRHR2	5.22e-05	2	165	2	ctd:C113202
Drug	bromoacetylcholamine	DTNA DTNB	5.22e-05	2	165	2	CID000192097
Drug	2-amino-4-phosphonobutyric acid	GRM1 GRM2 GRM3 ADCY7 TAF1 GRIN3B	5.30e-05	91	165	6	CID000002207
Drug	isoxazole	SYNE1 ABCC5 GRM2 GRM3 ECEL1	5.33e-05	56	165	5	CID000009254
Drug	AC1NUW3V	GRM1 GRM2 GRM3 GRIN3B	5.48e-05	29	165	4	CID005462126
Drug	ketobemidone	GRM1 GRM2 GRM3 GRIN3B	5.48e-05	29	165	4	CID000010101
Drug	cyclobutylene AP5	GRM1 GRM2 GRM3	5.91e-05	11	165	3	CID000126582
Drug	cis-2,3-piperidine dicarboxylic acid	GRM1 GRM2 GRM3 GRIN3B	6.29e-05	30	165	4	CID000001226
Drug	LY293558	GRM1 GRM2 GRM3 GRIN3B	6.29e-05	30	165	4	CID000127894
Drug	GYKI 53655	GRM1 GRM2 GRM3 GRIN3B	6.29e-05	30	165	4	CID000126757
Drug	AC1L32TU	GRM1 GRM2 GRM3 GRIN3B	6.29e-05	30	165	4	CID000107831
Drug	nitroxyl	IL12RB2 BIRC6 MADD GUCY2C SUPT16H TAF1 GRIN3B IL1R1	6.33e-05	185	165	8	CID000000945
Drug	LY235959	GRM1 GRM2 GRM3 GRIN3B	7.18e-05	31	165	4	CID000131938
Drug	eliprodil	GRM1 GRM2 GRM3 GRIN3B	7.18e-05	31	165	4	CID000060703
Drug	alpha-methyl-4-carboxyphenylglycine	GRM1 GRM2 GRM3 GRIN3B	8.16e-05	32	165	4	CID000001222
Drug	verlukast	ABCC5 AR CCL2 IL4	8.16e-05	32	165	4	ctd:C059141
Drug	6,7-dinitroquinoxaline	GRM3 CRHR1 CRHR2 GRIN3B	9.24e-05	33	165	4	CID002724608
Drug	Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A	DTNA SYNE1 GIT2 AR PREX2 CRHR2 MTA1 DSTYK	9.47e-05	196	165	8	6504_UP
Drug	rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	DNAH3 DTNA WRN GIT2 RANBP17 IRS2 SLC35E3 IL1R1	9.81e-05	197	165	8	1658_DN
Drug	Ethisterone [434-03-7]; Up 200; 12.8uM; HL60; HT_HG-U133A	RALGDS PGLYRP4 PPP4R4 GUCY2C DSTYK RABGAP1L IL1R1 TRAPPC9	9.81e-05	197	165	8	2366_UP
Drug	Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; HL60; HT_HG-U133A	NR2F6 SYNE1 ACOX1 DSTYK TRAPPC10 SLC35E3 SGSM3 SOS1	9.81e-05	197	165	8	1335_DN
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SEMA3F DTNA NR2F1 PPP4R4 URB1 MTA1 IRS2 PLD2	9.81e-05	197	165	8	3247_UP
Drug	Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A	DTNB EVPL GRM1 NR2F1 CRHR2 URB1 CCL2 TRAPPC9	9.81e-05	197	165	8	3209_UP
Drug	MSOPPE	GRM1 GRM2 GRM3	1.01e-04	13	165	3	CID005311463
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A	SEMA3F DNAH3 NR2F6 DYRK4 NR2F1 PI4KA TRAPPC10 SNX11	1.02e-04	198	165	8	762_UP
Drug	Chlorthalidone [77-36-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RALGDS DTNA AR FANCE RABGAP1L TAF1 SGSM3 KIF1C	1.02e-04	198	165	8	3198_DN
Drug	D-CPPene	GRM1 GRM2 GRM3 GRIN3B	1.04e-04	34	165	4	CID006435801
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A	GRM2 NR2F1 CRHR2 TRANK1 DSTYK ECEL1 SGSM3 KIF1C	1.05e-04	199	165	8	5954_DN
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; PC3; HT_HG-U133A	DTNB CRHR1 CRHR2 CLDN17 CIBAR1 CCL2 SLC35E3 IL1R1	1.09e-04	200	165	8	6606_UP
Drug	(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A	RALGDS DTNA DSTYK TRAPPC10 TIMELESS IRS2 PLEC SOS1	1.09e-04	200	165	8	4841_DN
Drug	kainite	GRM1 GRM2 GRM3 GRIN3B	1.17e-04	35	165	4	CID000164810
Drug	DR-0	NR2C2 NR2F6 NR2F1 NR2F2	1.17e-04	35	165	4	CID010062716
Drug	MTPG	GRM1 GRM2 GRM3	1.28e-04	14	165	3	CID005311456
Drug	2-methyl-6-styrylpyridine	GRM1 GRM2 GRM3	1.28e-04	14	165	3	CID000235382
Drug	R,S)-AMPA	GRM1 GRM2 GRM3 GRIN3B	1.31e-04	36	165	4	CID000001221
Drug	C6H12NO5P	GRM1 GRM2 GRM3 GRIN3B	1.31e-04	36	165	4	CID000104962
Drug	Sistan	CLSTN2 GRM3 WDR11 TAF1	1.31e-04	36	165	4	CID003001858
Drug	gacyclidine	GRM1 GRM2 GRM3 GRIN3B	1.31e-04	36	165	4	CID000176265
Drug	glutamic acid diethyl ester	GRM1 GRM2 GRM3 GRIN3B	1.31e-04	36	165	4	CID000073960
Drug	DCG-IV	GRM1 GRM2 GRM3 TAF1 GRIN3B	1.36e-04	68	165	5	CID000115114
Drug	Turbuhaler	CFHR1 ABCC5 ABCC6 ADRB2 CCL24 IL4	1.38e-04	108	165	6	CID000002462
Drug	Compound 10	SYNE1 CLSTN2 GRM2 TMEM121	1.46e-04	37	165	4	CID003749170
Drug	anastrozole	AR FANCE MTA1 SUPT16H	1.46e-04	37	165	4	CID000002187
Drug	benzyloxyaspartate	GRM1 GRM2 GRM3 GRIN3B	1.46e-04	37	165	4	CID004133412
Drug	isospaglumic acid	GRM2 GRM3	1.56e-04	3	165	2	ctd:C027172
Drug	Propionates	GRM1 SLC5A8	1.56e-04	3	165	2	ctd:D011422
Drug	Methacholine Compounds	ADRB2 IL4	1.56e-04	3	165	2	ctd:D008688
Drug	LY 379268	GRM2 GRM3	1.56e-04	3	165	2	ctd:C118218
Drug	P-44	ACOX1 CRHR1 CRHR2	1.60e-04	15	165	3	CID000200876
Drug	1-aminocyclopentane-1,3-dicarboxylate	GRM1 GRM2 GRM3 ADCY7 PLD2 GRIN3B	1.60e-04	111	165	6	CID000001310
Drug	L-BMAA	GRM1 GRM2 GRM3 GRIN3B	1.62e-04	38	165	4	CID000028558
Drug	CGS 19755	GRM1 GRM2 GRM3 GRIN3B	1.62e-04	38	165	4	CID000068736
Drug	AC1L1CBF	RALGDS DTNB ADCY7 CRHR1 CRHR2 FANCE ADRB2 MTNR1A CCL2 SOS1	1.78e-04	336	165	10	CID000001822
Drug	HA-966	GRM1 GRM2 GRM3 GRIN3B	1.79e-04	39	165	4	CID000001232
Drug	DETC-MeSO	GRM1 GRM2 GRM3 GRIN3B	1.79e-04	39	165	4	CID003035711
Drug	ethylglutamate	GRM1 GRM2 GRM3	1.95e-04	16	165	3	CID000014241
Drug	2-PMPA	GRM1 GRM2 GRM3	1.95e-04	16	165	3	CID010130754
Disease	Endometrioma	NR2C1 NR2C2 NR2F6 LRRK2 NR2F2 DDX5 MTA1 IL1R1	2.65e-06	161	158	8	C0269102
Disease	Endometriosis	NR2C1 NR2C2 NR2F6 LRRK2 NR2F2 DDX5 MTA1 IL1R1	2.65e-06	161	158	8	C0014175
Disease	type 2 diabetes mellitus (implicated_via_orthology)	NR2F6 AR NR2F1 NR2F2 MADD IRS2	2.23e-05	105	158	6	DOID:9352 (implicated_via_orthology)
Disease	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C measurement	CFH MGAT4C	2.85e-05	2	158	2	EFO_0802264
Disease	anaphase-promoting complex subunit 7 measurement	CFH CFHR1	8.52e-05	3	158	2	EFO_0801381
Disease	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH CFHR1	8.52e-05	3	158	2	C2749604
Disease	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	CFH CFHR1	8.52e-05	3	158	2	235400
Disease	calnexin measurement	CFH CFHR1	8.52e-05	3	158	2	EFO_0801444
Disease	Hemolytic uremic syndrome, atypical, susceptibility to, 1	CFH CFHR1	8.52e-05	3	158	2	cv:C2749604
Disease	functional colonic disease (biomarker_via_orthology)	CRHR1 CRHR2	8.52e-05	3	158	2	DOID:3877 (biomarker_via_orthology)
Disease	Addicted to cocaine	GRM2 GRM3	8.52e-05	3	158	2	C0858355
Disease	complement factor H-related protein 4A measurement	CFH CFHR1	8.52e-05	3	158	2	EFO_0600057
Disease	tubulin polymerization-promoting protein family member 2 measurement	CFH PLEKHG4	8.52e-05	3	158	2	EFO_0802164
Disease	histone-lysine N-methyltransferase 2D measurement	CFH CFHR1	8.52e-05	3	158	2	EFO_0801683
Disease	Colorectal Carcinoma	TET2 RALGDS DNAH3 ABCA4 SYNE1 WRN ABCC5 CLSTN2 GRM1 ABCC6 PREX2 GUCY2C PRG2	1.10e-04	702	158	13	C0009402
Disease	Age-related macular degeneration	CFH CFHR1 ABCA4	1.16e-04	18	158	3	cv:C0242383
Disease	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement	CFH CFHR1	1.70e-04	4	158	2	EFO_0803292
Disease	C-C motif chemokine 24 measurement	CFH CCL24	1.70e-04	4	158	2	EFO_0020197
Disease	kallikrein-5 measurement	CFH CFHR1	1.70e-04	4	158	2	EFO_0020515
Disease	Pneumonitis	CCL2 CCL24 IL1R1 IL4	2.03e-04	54	158	4	C3714636
Disease	Pneumonia	CCL2 CCL24 IL1R1 IL4	2.03e-04	54	158	4	C0032285
Disease	Lobar Pneumonia	CCL2 CCL24 IL1R1 IL4	2.03e-04	54	158	4	C0032300
Disease	Experimental Lung Inflammation	CCL2 CCL24 IL1R1 IL4	2.03e-04	54	158	4	C0887898
Disease	asthma (is_implicated_in)	CRHR1 CRHR2 ADRB2 CCL2 CCL24 IL4	2.08e-04	157	158	6	DOID:2841 (is_implicated_in)
Disease	Epilepsy, Benign Psychomotor, Childhood	GRM1 GRM2 GRM3	2.47e-04	23	158	3	C0393672
Disease	Epilepsy, Lateral Temporal	GRM1 GRM2 GRM3	2.47e-04	23	158	3	C0393682
Disease	Uncinate Epilepsy	GRM1 GRM2 GRM3	2.47e-04	23	158	3	C0014558
Disease	Epilepsy, Temporal Lobe	GRM1 GRM2 GRM3	2.47e-04	23	158	3	C0014556
Disease	Mood Disorders	GRM3 AR ADCY7 CRHR1 CRHR2 TIMELESS	3.00e-04	168	158	6	C0525045
Disease	Insulin Sensitivity	AR ADRB2 CCL2 IRS2	3.06e-04	60	158	4	C0920563
Disease	Insulin Resistance	AR ADRB2 CCL2 IRS2	3.06e-04	60	158	4	C0021655
Disease	brain connectivity measurement	SEMA3F RDH14 CPED1 C17orf58 PLEC LINC02694 MOB4 TANGO6 SOS1	3.21e-04	400	158	9	EFO_0005210
Disease	COVID-19 (is_marker_for)	CXCL16 CCL2 IL1R1 IL4	3.69e-04	63	158	4	DOID:0080600 (is_marker_for)
Disease	Allergic Reaction	CCL2 CCL24 IL1R1 IL4	3.69e-04	63	158	4	C1527304
Disease	Hypersensitivity	CCL2 CCL24 IL1R1 IL4	3.92e-04	64	158	4	C0020517
Disease	Membranoproliferative Glomerulonephritis, Type II	CFH CFHR1	4.21e-04	6	158	2	C0268743
Disease	complement C1s subcomponent measurement	CFH CFHR1	4.21e-04	6	158	2	EFO_0008091
Disease	glial fibrillary acidic protein measurement	CFH PRG2	4.21e-04	6	158	2	EFO_0020404
Disease	non-alcoholic fatty liver disease severity measurement	PTPRG LINC02694 TRAPPC9	4.47e-04	28	158	3	EFO_0008421
Disease	Age related macular degeneration	CFH CFHR1 ABCA4	5.50e-04	30	158	3	C0242383
Disease	epidermolysis bullosa simplex (is_implicated_in)	DST PLEC	5.88e-04	7	158	2	DOID:4644 (is_implicated_in)
Disease	Alcoholic Intoxication, Chronic	GRM1 GRM2 GRM3 AR ADCY7 CRHR1 LINC02694	6.27e-04	268	158	7	C0001973
Disease	anterior uveitis (is_implicated_in)	CFH CCL2	7.81e-04	8	158	2	DOID:1407 (is_implicated_in)
Disease	hepatitis A virus cellular receptor 2 measurement	CFH ABCC6	7.81e-04	8	158	2	EFO_0008151
Disease	irritable bowel syndrome (biomarker_via_orthology)	CRHR1 CRHR2	7.81e-04	8	158	2	DOID:9778 (biomarker_via_orthology)
Disease	Leishmaniasis, Cutaneous	CCL2 IL4	7.81e-04	8	158	2	C0023283
Disease	sphingomyelin 16:1 measurement	RALGDS NKX1-1	7.81e-04	8	158	2	EFO_0010392
Disease	Urban cutaneous leishmaniasis	CCL2 IL4	7.81e-04	8	158	2	C0086541
Disease	Leishmaniasis, New World	CCL2 IL4	7.81e-04	8	158	2	C0086540
Disease	gdnf family receptor alpha-1 measurement	CFH GFRA1	7.81e-04	8	158	2	EFO_0020400
Disease	atypical hemolytic-uremic syndrome (is_implicated_in)	CFH CFHR1	7.81e-04	8	158	2	DOID:0080301 (is_implicated_in)
Disease	kidney disease	CFH HORMAD2	7.81e-04	8	158	2	EFO_0003086
Disease	Atypical hemolytic-uremic syndrome	CFH CFHR1	1.00e-03	9	158	2	cv:C2931788
Disease	C3 glomerulopathy	CFH CFHR1	1.00e-03	9	158	2	C4087273
Disease	Hemolytic-uremic syndrome	CFH CFHR1	1.00e-03	9	158	2	cv:C0019061
Disease	leukocyte immunoglobulin-like receptor subfamily A member 5 measurement	CFH CFHR1	1.00e-03	9	158	2	EFO_0801766
Disease	vital capacity	CFH TET2 HORMAD2 ADAMTSL1 SYNE1 POLR2B ZNF629 RDH14 UNC13D PKD1L3 DDX5 FANCE ADRB2 DST LINC02694 IL1R1	1.01e-03	1236	158	16	EFO_0004312
Disease	sex interaction measurement, Crohn's disease	LRRK2 CCL2 LINC02694	1.02e-03	37	158	3	EFO_0000384, EFO_0008343
Disease	mean platelet volume	SEMA3F TET2 MYO5A DOCK11 ACOX1 LRRK2 ABCC5 UNC13D TRANK1 PI4KA DSTYK EPC1 IRS2 PLEC	1.22e-03	1020	158	14	EFO_0004584
Disease	Atypical Hemolytic Uremic Syndrome	CFH CFHR1	1.25e-03	10	158	2	C2931788
Disease	membranoproliferative glomerulonephritis (implicated_via_orthology)	CFH CCL2	1.25e-03	10	158	2	DOID:2920 (implicated_via_orthology)
Disease	abdominal obesity-metabolic syndrome (implicated_via_orthology)	DDX5 GUCY2C	1.25e-03	10	158	2	DOID:0060611 (implicated_via_orthology)
Disease	Fuchs endothelial corneal dystrophy	CFH PTPRG	1.25e-03	10	158	2	Orphanet_98974
Disease	Pleural Diseases	CCL2 IL4	1.25e-03	10	158	2	C0032226
Disease	chronic obstructive pulmonary disease	TET2 FNDC3B ADAMTSL1 ZSCAN9 VPS54 ARMC2 PPP4R4 SPATS2L ADRB2 DSTYK EPC1	1.25e-03	688	158	11	EFO_0000341
Disease	white matter microstructure measurement	ZSCAN9 ABCC5 UNC13D CPED1 C17orf58 PLEC LINC02694 SOS1	1.25e-03	390	158	8	EFO_0005674
Disease	testosterone measurement	TET2 HORMAD2 NR2F6 MYO5A ZNF629 UNC13D BIRC6 AR URB1 PTPRG WDR11 KNDC1 YY1AP1 MINAR1 PLEKHM3 SOS1	1.40e-03	1275	158	16	EFO_0004908
Disease	hemopexin measurement	CFH CFHR1	1.52e-03	11	158	2	EFO_0008149
Disease	psoriasis (is_marker_for)	CFH ADRB2 IL4	1.70e-03	44	158	3	DOID:8893 (is_marker_for)
Disease	fibrinogen measurement, tissue plasminogen activator measurement	PKD1L3 PLEC IL1R1	1.81e-03	45	158	3	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	PKD1L3 PLEC IL1R1	1.81e-03	45	158	3	EFO_0004623, EFO_0004792
Disease	rhinitis (is_marker_for)	CRHR1 CRHR2 CCL24	1.93e-03	46	158	3	DOID:4483 (is_marker_for)
Disease	hemoglobin A1 measurement	TET2 FNDC3B UNC13D CRHR2 MADD SLC22A16 IRS2 LINC02694 KIF1C	2.03e-03	520	158	9	EFO_0007629
Disease	calcium measurement	CFH TET2 LRP1B ABCC6 TMEM121 PPP4R4 IRS2 PLEC MVB12B SOS1	2.13e-03	628	158	10	EFO_0004838
Disease	N-acetyl-isoputreanine measurement	SPATS2L KIF1C	2.14e-03	13	158	2	EFO_0800107
Disease	risky sexual behaviour measurement	TET2 PKD1L3 BIRC6 C17orf58 CLDN17	2.21e-03	169	158	5	EFO_0007877
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	PI4KAP2 PI4KA	2.49e-03	14	158	2	DOID:0060413 (implicated_via_orthology)
Disease	anti-basement membrane glomerulonephritis (implicated_via_orthology)	CCL2 IL4	2.49e-03	14	158	2	DOID:4780 (implicated_via_orthology)
Disease	Mental Depression	GRM1 AR ADCY7 CRHR1 CRHR2 TIMELESS	2.54e-03	254	158	6	C0011570
Disease	fibrinogen measurement	PKD1L3 WDR11 PLEC IL1R1	2.85e-03	109	158	4	EFO_0004623
Disease	Uveal Melanoma	ADAMTSL1 LRP1B GFRA1	2.90e-03	53	158	3	EFO_1000616
Disease	systemic scleroderma (is_marker_for)	CXCL16 CCL2 IL4	2.90e-03	53	158	3	DOID:418 (is_marker_for)
Disease	inflammatory bowel disease	TET2 HORMAD2 IL12RB2 UBR4 LRRK2 ADCY7 CCL2 LINC02694	2.99e-03	449	158	8	EFO_0003767
Disease	pneumonia, COVID-19	ADAMTSL1 LRP1B MTNR1A TRAPPC9	3.24e-03	113	158	4	EFO_0003106, MONDO_0100096
Disease	cathepsin L1 measurement	LRRK2 GRM1	3.25e-03	16	158	2	EFO_0010619
Disease	temporal arteritis (is_implicated_in)	CCL2 IL4	3.25e-03	16	158	2	DOID:13375 (is_implicated_in)
Disease	dual specificity mitogen-activated protein kinase kinase 2 measurement	CFH PPP4R4	3.25e-03	16	158	2	EFO_0008112
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	PKD1L3 PLEC IL1R1	3.39e-03	56	158	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	forced expiratory volume	TET2 HORMAD2 ADAMTSL1 SYNE1 ZNF629 RDH14 ARMC2 SPATS2L ADRB2 DST WDR11	3.60e-03	789	158	11	EFO_0004314
Disease	response to phenylephrine	CLSTN2 F2RL2	3.68e-03	17	158	2	EFO_0010152
Disease	Autoimmune Chronic Hepatitis	CCL2 IL4	3.68e-03	17	158	2	C0241910
Disease	systemic lupus erythematosus, COVID-19	IL12RB2 ZSCAN9 CRHR1	3.75e-03	58	158	3	MONDO_0007915, MONDO_0100096
Disease	fibrinogen measurement, factor VII measurement	PKD1L3 PLEC IL1R1	3.75e-03	58	158	3	EFO_0004619, EFO_0004623
Disease	Colorectal Neoplasms	TET2 ABCA4 SYNE1 ABCC5 ABCC6 GUCY2C	3.88e-03	277	158	6	C0009404
Disease	lupus nephritis (is_implicated_in)	CFH CCL2	4.12e-03	18	158	2	DOID:0080162 (is_implicated_in)
Disease	Anorexia	CRHR1 CRHR2	4.12e-03	18	158	2	C0003123
Disease	free androgen index	TET2 NR2F6 AR URB1 PTPRG WDR11 MINAR1	4.14e-03	374	158	7	EFO_0007005
Disease	pain	HORMAD2 PKD1L3 CRHR1 RABGAP1L IL1R1	4.17e-03	196	158	5	EFO_0003843
Disease	Bipolar Disorder	SYNE1 GRM3 CRHR1 CRHR2 TRANK1 ADRB2 TIMELESS LINC02694	4.30e-03	477	158	8	C0005586
Disease	glucose measurement	TET2 HORMAD2 ARMC2 MADD ADRB2 PIK3C2G USP47	4.51e-03	380	158	7	EFO_0004468

Protein segments in the cluster

Peptide	Gene	Start	Entry
HACYTVRRFSIRNTK	PTPRG	986	P23470
CRKLYRSINRTGTAQ	EPC1	546	Q9H2F5
FQELLCLRRSSLKAY	ADRB2	336	P07550
RVVSYQLSSRSTCLK	CCL24	46	O00175
KTCVDTYTNRLRSKR	BIRC6	4441	Q9NR09
ICLFYQTLTLRGSRK	CPED1	26	A4D0V7
FSQRRGAKTVRYALC	ABCA4	216	P78363
RTLRCKAFYSVNGSV	AJUBA	371	Q96IF1
CTNIARIFSKLTSYR	ARMC2	491	Q8NEN0
FKSYRTIFSCLNRIK	COQ3	61	Q9NZJ6
CYSALLTKTNRIARI	GRM2	646	Q14416
YSALLTKTNCIARIF	GRM3	656	Q14832
SYRLNKICSGLSFQR	BRPF3	481	Q9ULD4
FILTAALSYVLCKRR	CXCL16	216	Q9H2A7
RLLTSSAYRLQSECK	GIT2	701	Q14161
VKVASVLAYSFSRRC	APPBP2	91	Q92624
SVEFVCKRGYRLSSR	CFH	1196	P08603
RDLFTYTVKCIQIRR	ADCY7	206	P51828
SEITYCRRNFLNRTS	DHX29	1156	Q7Z478
RFRIKCSELNGRYTS	CLSTN2	766	Q9H4D0
RQARVRLQCKFYSSL	CLDN17	56	P56750
FRCRTTFYTALTRLL	RANBP17	661	Q9H2T7
RNSRRSKGIAYVEFC	RBM23	201	Q86U06
FFKRSIRKNLVYSCR	NR2C1	136	P13056
CKSFFKRSIRRNLSY	NR2F6	76	P10588
KRSIRRNLSYTCRSN	NR2F6	81	P10588
FKRSVRKNLTYSCRS	NR2C2	141	P49116
CKSFFKRSVRRNLTY	NR2F1	106	P10589
KRSVRRNLTYTCRAN	NR2F1	111	P10589
SFFKRSVRRNLSYTC	NR2F2	101	P24468
YTLSCRDRNEKIFRV	GUCY2C	681	P25092
VSRQCLLTLIRKYDF	PIK3C2G	401	O75747
KQRRQCSTYLRLGEF	MGAT4C	421	Q9UBM8
LLSSSYKTRTCRCRT	LRP1B	491	Q9NZR2
FSTFRECLYTLKRLV	MADD	186	Q8WXG6
YNKRLKRIVFFSCRS	MAF1	191	Q9H063
ATDRFRSLYSKCNVL	DST	4021	Q03001
KKLFATSISCITYLR	HORMAD2	36	Q8N7B1
LLRSSSSYVKRFNRK	C17orf58	311	Q2M2W7
RIKFQKASVSRCTLY	IL12RB2	231	Q99665
RTYGRLFQKLCSSSA	KCNT1	1001	Q5JUK3
FLECGKTNLRRTTYL	DDX5	231	P17844
LSSKSCEGRNIRYRT	ADAMTSL1	61	Q8N6G6
IIFSVRYRAASRSSK	OR4K13	221	Q8NH42
VRDIQSFYIDRLKSC	PGLYRP4	256	Q96LB8
QYSIEAALRCRRISK	EVPL	1746	Q92817
ERQCALRVFKARIYT	FBXO39	391	Q8N4B4
TYSTERLRKCLFLFI	CRHR2	216	Q13324
KVIQSCFLSNRSRTY	PI4KA	2076	P42356
LSTLRYADRTKQIRC	KIF1C	336	O43896
GSTLYTKANLILCRR	LMO3	51	Q8TAP4
TRRLIRVIYNFCNSV	LRRK2	2441	Q5S007
RCQLEVKLNTSRTFY	GARIN5A	196	Q6IPT2
TSCSRRFYQLTKLLD	AR	851	P10275
QRLKSLRAYLFSCRA	PLEKHM3	606	Q6ZWE6
ESCKLRRLRFTYGTQ	DSTYK	146	Q6XUX3
TEASYSRFLRKAECI	ECEL1	636	O95672
TRYLCFTRSFSKENS	MVB12B	91	Q9H7P6
SRILYSFCTAFKRSS	RABGAP1L	241	Q5R372
FRTRSICTTVFYTNL	F2RL2	121	O00254
TCRRTLFGDYSLKTR	INTU	691	Q9ULD6
LGNLTVIYTFCRSRS	OPN4	86	Q9UHM6
TCRYLLVRSLQTFSQ	PRG2	106	P13727
KNLTGVYRLCLSART	IRS2	211	Q9Y4H2
STTSCKLRLDYRSGR	ITPRIPL1	346	Q6GPH6
ASRLTAYFRRKCVAA	ABCC5	336	O15440
KFTSIRRVRGDNYCA	OTULIN	116	Q96BN8
LKTYDTSFLDFLRRC	DYRK4	366	Q9NR20
SYKAFSAARVTARVR	DUOXA2	86	Q1HG44
RALSKACTIAIRYSA	ACOX1	291	Q15067
FQAATYLCLLRSIRK	FMC1	61	Q96HJ9
KETFCRAATVLRQFY	IL4	66	P05112
VYSRRCVSFILRATV	HEATR5B	351	Q9P2D3
RNVNYSLASFLKRCL	DOCK11	1021	Q5JSL3
CQIFAAYVRKTARLR	CIBAR1	31	A1XBS5
RSLAQKIVATYRLCS	DNAH3	1576	Q8TD57
KTNYICRSRLADFFT	GFRA1	251	P56159
QRLASYRRITSSKCP	CCL2	46	P13500
KVQRLTEFTCYSFRI	FNDC3B	1016	Q53EP0
GIKLRRTNYSLRFNC	CRACD	846	Q6ZU35
NFDVIRLSTYRTACK	DTNB	26	O60941
RLSTYRTACKLRFVQ	DTNB	31	O60941
FYCFLNSEVRSAIRK	CRHR1	391	P34998
RECRILKNFSSLYAI	RALGDS	471	Q12967
RLSTYRTACKLRFVQ	DTNA	31	Q9Y4J8
KLRRSNRQTSCYSKT	FBXO47	16	Q5MNV8
LRRCFSTTLLYCRKS	GPR85	346	P60893
TFTKIYRRSLCVLQA	KNDC1	1311	Q76NI1
RLLTTALTSFCAKYT	FANCE	381	Q9HB96
AEFVCKRGYRLSSRS	CFHR1	296	Q03591
CYSALVTKTNRIARI	GRM1	671	Q13255
CSNISFYLILKARRV	UTP3	276	Q9NQZ2
CVVRNSSYCLRIKIS	IL1R1	96	P14778
RFLCIAFSYIRILTT	OR1L8	211	Q8NGR8
SQLAKLRSVLFYTAC	MINAR1	41	Q9UPX6
TLIFRSRRYCLKSCD	FSCN2	176	O14926
KVVCFYRRRDISNTL	MTA3	41	Q9BTC8
NLCYAILFRRTVSSK	GRIN3B	621	O60391
RQCTFRTFTRIFSAK	HSFX1	166	Q9UBD0
RLKLATGRTFYLQLC	GARIN3	141	Q8TC56
SKTTRFCLICNYVSR	RFC4	171	P35249
SKAFTAKTSCVRRRY	SNX11	46	Q9Y5W9
TSYRCILRACLVRSK	NUGGC	526	Q68CJ6
ASRTLCIFLRYNRKQ	PPP4R4	546	Q6NUP7
QACSRYTASSKRRSR	SEMA3F	571	Q13275
SSVAKLGSVCRRIYR	MOB4	151	Q9Y3A3
CVYCTKRFTASSILR	PRDM14	491	Q9GZV8
KDLQRCTVSLTRYRV	SPATS2L	226	Q9NUQ6
LCRFSRDLSTYSGKV	SYNE1	3026	Q8NF91
KATRYLSVCERLNLA	NKX1-1	316	Q15270
KFRATRYLSVCERLN	NKX1-2	181	Q9UD57
FQSLYVVSSCQLRRL	ABCC6	1101	O95255
VNYVLKCREVRSRAS	PLEKHG4	1066	Q58EX7
TLDYNCRKTLRRFLS	RFLNB	181	Q8N5W9
KVGRRTVLAYSLFCS	SLC22A16	411	Q86VW1
LNSSATGRCLKIYRT	TAF1	1156	P21675
RRYNVLSKNCFVTRI	PTPN14	11	Q15678
SCTYLSRNFIRISSK	PKD1L3	111	Q7Z443
SVYSRLVLCKTFRLD	SGSM3	606	Q96HU1
RYTKRDCSTFLRTSE	POLR2B	886	P30876
RYISCKSRFQAKLSL	SLC5A8	266	Q8N695
VSLYLNLSRCRRKTN	TANC1	1336	Q9C0D5
KYLHSSRCRRQIILS	WRN	901	Q14191
CYSRSKLANILFTRE	RDH14	216	Q9HBH5
KVVCFYRRRDISSTL	MTA1	41	Q13330
KVIQSCFLSNRSRTY	PI4KAP2	566	A4QPH2
AKRRLSESACRFYSQ	SOS1	396	Q07889
GIRFKSYCSNLVRTL	SUPT16H	276	Q9Y5B9
KDSAVRSSIFRLYSR	URB1	2141	O60287
LKRQTLCRYRLETFS	SSUH2	106	Q9Y2M2
LCRYRLETFSESRIS	SSUH2	111	Q9Y2M2
IRRALRDYKQVTASC	ABTB1	81	Q969K4
RVCIYRRRTNSTTTK	CLDN34	56	H7C241
YLGKSTRRRACQSLL	LINC02694	151	Q8NAA6
FLDYLKRFACSTVVR	TIMELESS	691	Q9UNS1
KRFACSTVVRAYVLL	TIMELESS	696	Q9UNS1
SRYCLSSRLRVSATF	TRBC1	71	P01850
KYASRSCVFRSTVQR	STPG4	151	Q8N801
ALATKACTFLEYRRQ	TMEM121	256	Q9BTD3
RCYNDLRLLSVSSKT	USP47	766	Q96K76
ATRRLYTSCKALLNV	TANGO6	191	Q9C0B7
FFSKIYQTEELRSCR	TEX10	526	Q9NXF1
LCQRISSYKKFSRVL	PREX2	896	Q70Z35
ALRRKYSCDRSATVT	PLEC	881	Q15149
YLLTCKTARQLTVRI	YY1AP1	311	Q9H869
IRNSQTRKICHSLYF	USP41	261	Q3LFD5
RLSLLQRYFKDSSCL	UBR3	1296	Q6ZT12
RYCTEGKRTFSSRLI	ZNF687	1026	Q8N1G0
FFRIYKRICSVSQIS	TRAPPC9	31	Q96Q05
SRYCLSSRLRVSATF	TRBC2	71	A0A5B9
IRNSQTRKICHSLYF	USP18	261	Q9UMW8
SQCSKSYSRRSFLIE	ZSCAN9	341	O15535
LRSYLFSRQCTLLLF	TRAPPC10	306	P48553
RLCQITRSLLGKTYR	TRANK1	2131	O15050
CITLRVRRSYNNIFT	WDR11	311	Q9BZH6
SQRRGLLSSKTYICS	ZNF629	651	Q9UEG4
TLLSTSYRKACVLQR	UBR4	536	Q5T4S7
NECSKTFRLRSYLAS	ZNF600	501	Q6ZNG1
TLRKYGTLTNRRCAL	TET2	1251	Q6N021
HRSLILKCSSYRQAR	PLD2	286	O14939
KLTLRATYDNCTRRV	ZP2	96	Q05996
ASSRELIRKYFCSRI	UNC13D	886	Q70J99
CYQKTFSTRIQLTLI	SLC35E3	121	Q7Z769
RTLRYKQSCRSSLAE	WWC3	946	Q9ULE0
TRLSDLLKYFNSRSC	VPS54	771	Q9P1Q0
TQCRKAFRSVKYLRV	ZNF878	286	C9JN71
IRQCILTRDSSIFKY	ZNF114	146	Q8NC26
EYTFCVTSLRNSRRF	ELFN2	356	Q5R3F8
NFRKEYRRIIVSLCT	MTNR1A	301	P48039
RQYVLCTLSRITTFD	LRRC51	146	Q96E66
RCYAKFLRRTKAATI	MYO5A	806	Q9Y4I1